Follow-up of Intensive Glucose Control in Type 2 Diabetes.

被引：1
|
作者：
Muehlhauser, Ingrid [1 ]
机构：
[1] Univ Hamburg, D-20146 Hamburg, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [21] Intensive follow-up of control subjects: Is it necessary?
    Alderman, BW
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) : 744 - 745
  • [22] Intensive glucose control in patients with type-2 diabetes
    Pavlicek, V.
    DIABETOLOGE, 2008, 4 (07): : 557 - 558
  • [23] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    Diabetologia, 2009, 52 : 2470 - 2470
  • [24] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    F. M. Turnbull
    C. Abraira
    R. J. Anderson
    R. P. Byington
    J. P. Chalmers
    W. C. Duckworth
    G. W. Evans
    H. C. Gerstein
    R. R. Holman
    T. E. Moritz
    B. C. Neal
    T. Ninomiya
    A. A. Patel
    S. K. Paul
    F. Travert
    M. Woodward
    Diabetologia, 2009, 52 : 2288 - 2298
  • [25] Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes
    MacIsaac, Richard J.
    Jerums, George
    HEART LUNG AND CIRCULATION, 2011, 20 (10): : 647 - 654
  • [26] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    Turnbull, F. M.
    Abraira, C.
    Anderson, R. J.
    Byington, R. P.
    Chalmers, J. P.
    Duckworth, W. C.
    Evans, G. W.
    Gerstein, H. C.
    Holman, R. R.
    Moritz, T. E.
    Neal, B. C.
    Ninomiya, T.
    Patel, A. A.
    Paul, S. K.
    Travert, F.
    Woodward, M.
    DIABETOLOGIA, 2009, 52 (11) : 2288 - 2298
  • [27] Follow-up of type 2 diabetes patients (excluding complications)
    Charbonnel, B
    Aptel, I
    Amouyel, P
    Attali, JR
    Aulanier, S
    Balarac, N
    Bukowski, JV
    Cathelineau, B
    de Broucker, T
    Denis, C
    Mausset, J
    Ormières, JJ
    Passa, P
    Paulhan, A
    Pousset, F
    Pouteil-Noble, C
    Laversin, S
    Anouchian, P
    Aquino, JP
    Aubert, JP
    Baufine-Ducrocq, H
    Bernard, MH
    Bonnet, A
    Chabassol, E
    Cirioni, A
    Colas, C
    Cordonnier, D
    Coscas, G
    Cuvelier, D
    Dany, F
    Derrien, G
    Desrousseaux, B
    Dueymes, JM
    Dupasquier, JP
    Dussart, L
    Gemez-Lestradet, C
    Gerson, M
    Grimaldi, A
    Gros, M
    Guerot, C
    Guyot-Argenton, C
    Halimi, S
    Kourilsky, O
    Lanéelle, D
    Laudet, J
    Lelong, S
    Malinsky, M
    Meffre, C
    Moulin, P
    Olaya, E
    PRESSE MEDICALE, 1999, 28 (19): : 1023 - 1027
  • [28] The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes.
    Mathisen, AL
    Schneider, R
    Rubin, C
    Houser, V
    DIABETOLOGIA, 1999, 42 : A227 - A227
  • [29] Telemedicine Influence on the Follow-Up of Type 2 Diabetes Patients
    Rodriguez-Idigoras, Maria I.
    Sepulveda-Munoz, Jesus
    Sanchez-Garrido-Escudero, Ramon
    Martinez-Gonzalez, Jose L.
    Escolar-Castello, Jose L.
    Paniagua-Gomez, Isabel M.
    Bernal-Lopez, Rosa
    Fuentes-Simon, Maria V.
    Garofano-Serrano, Daniel
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (07) : 431 - 437
  • [30] Improving glucose control and cardiovascular risk in general practice Type 2 diabetes.
    Potts, NJ
    Holman, RR
    DIABETOLOGIA, 2003, 46 : A441 - A441
12345